Tribe Technology set to deliver healthy pipeline of orders from Tier-One miners. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,356.00
Bid: 12,390.00
Ask: 12,394.00
Change: 28.00 (0.23%)
Spread: 4.00 (0.032%)
Open: 12,364.00
High: 12,454.00
Low: 12,322.00
Prev. Close: 12,328.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Earnings, Trading Statements Calendar - Week Ahead

Thu, 23rd Jul 2015 15:14

UK Earnings, Trading Statements Calendar 
Friday, July 24 
Anglo AmericanHalf Year Results
BeazleyHalf Year Results
HammersonHalf Year Results
PearsonHalf Year Results
Volex GroupQ1 Interim Management Statement
Close BrothersTrading Update
Helical BarInterim Management Statement
LonminQ3 Interim Management Statement/Production Report
Vodafone GroupQ1 Interim Management Statement
AG BarrTrading Update
Monday, July 27 
DialightHalf Year Results
Reckitt BenckiserHalf Year Results
HiscoxHalf Year Results
Acacia MiningHalf Year Results
GoodwinFull Year Results
CranswickQ1 Interim Management Statement
XP PowerHalf Year Results
SeniorHalf Year Results
Fevertree DrinksHalf Year Results
Nakama GroupFull Year Results
Tuesday, July 28 
BPHalf Year Results
GKNHalf Year Results
NextQ2 Trading Statement
GreencoreInterim Management Statement
Provident Financial GroupHalf Year Results
McColl's RetailHalf Year Results
ShawbrookHalf Year Results
Virgin MoneyHalf Year Results
SEGROHalf Year Results
Tullett PrebonHalf Year Results
Rathbone BrothersHalf Year Results
InformaHalf Year Results
Domino's Pizza GroupHalf Year Results
ITVHalf Year Results
Jardine Lloyd ThompsonHalf Year Results
International Game TechnologyHalf Year Results
PaceHalf Year Results
Greencoat UK WindHalf Year Results
Burford CapitalHalf Year Results
Games Workshop Half Year Results
DraxHalf Year Results
ElementisHalf Year Results
CarpetrightHalf Year Results
Wednesday, July 29 
Brewin DolphinInterim Management Statement
Capital Counties & PropertiesHalf Year Results
AntofagastaQ2 Production Report
Compass GroupInterim Management Statement
DignityHalf Year Results
DiplomaQ3 Results
BarclaysHalf Year Results
British American TobaccoHalf Year Results
GlaxoSmithKlineQ2 Results
4imprintHalf Year Results
Jupiter Fund ManagementHalf Year Results
Lancashire HoldingsQ2 Resiults
RightmoveHalf Year Results
International Personal FinanceHalf Year Results
FoxtonsHalf Year Results
Pets At HomeTrading Update
Polymetal InternationalQ2 Production Report
TSB Banking GroupHalf Year Results
RenishawHalf Year Results
Tate & LyleInterim Management Statement
Tarsus GroupHalf Year Results
CapitaHalf Year Results
Taylor WimpeyHalf Year Results
Riverstone EnergyHalf Year Results
Stanley GibbonsTrading Update
Paragon GroupQ3 Interim Management Statement 
Aberforth Smaller Cos TrustHalf Year Results
SkyFull Year Results
JKX Oil & Gas Half Year Results
Circassia PharmaceuticalsHalf Year Results
St James's PlaceHalf Year Results
TymanHalf Year Results
WS AtkinsHalf Year Results
Law DebentureHalf Year Results
Mithras Investment TrustHalf Year Results
National ExpressHalf Year Results
Tullow OilHalf Year Results
Man GroupHalf Year Results
Telecity Half Year Results
Essar EnergyQ1 Results
FDM GroupHalf Year Results
IndiviorHalf Year Results
Mitchells & ButlersQ3 Interim Management Statement 
Thursday, July 30 
AstraZenecaHalf Year Results
Royal Dutch ShellHalf Year Results
CentricaHalf Year Results
Intercontinental Hotels GroupHalf Year Results
Halfords GroupQ1 Interim Management Statement 
InchcapeHalf Year Results
Moneysupermarket.comHalf Year Results
Hemderson GroupHalf Year Results
LairdHalf Year Results
Millennium & Copthorne HotelsHalf Year Results
SpectrisHalf Year Results
SchrodersHalf Year Results
BAE SystemsHalf Year Results
Rolls Royce HoldingsHalf Year Results
Royal Bank of Scotland GroupHalf Year Results
Babcock InternationalTrading Update
Smith & NephewHalf Year Results
CountrywideHalf Year Results
3i GroupInterim Management Statement
VictoriaFull Year Results
BodycoteHalf Year Results
BT GroupHalf Year Results
Centaur MediaHalf Year Results
CommunisisHalf Year Results
DiageoHalf Year Results
Intu PropertiesHalf Year Results
KAZ MineralsQ2 Production Report
Management Consulting Group Half Year Results
Merlin EntertainmentsHalf Year Results
RPS GroupHalf Year Results
Thomas CookQ3 Interim Management Statement 
Weir GroupHalf Year Results
XchangingHalf Year Results
Rentokil InitialHalf Year Results
RexamHalf Year Results
Robert WaltersHalf Year Results
  
Copyright 2015 Alliance News Limited. All Rights Reserved.

More News
17 Nov 2023 12:00

LONDON MARKET MIDDAY: Stocks shrug off downbeat UK retail sales

(Alliance News) - Stock prices in London were up at midday on Friday, as a week of favourable data as far as inflation goes gave investors a reason to overlook disappointing UK retail sales figures.

Read more
17 Nov 2023 09:03

LONDON MARKET OPEN: Stocks up despite UK retail sales growth miss

(Alliance News) - Stock prices in London opened higher on Friday, despite weaker-than-expected October retail sales figures for the UK.

Read more
17 Nov 2023 08:31

TOP NEWS: US approves AstraZeneca's Truqap for form of breast cancer

(Alliance News) - AstraZeneca PLC on Friday said that the US Food & Drug Administration approved its drug Truqap in combination with Faslodex to treat patients with an advanced form of breast cancer.

Read more
17 Nov 2023 07:58

LONDON BRIEFING: UK retail sales fall; AstraZeneca gets US approval

(Alliance News) - Stock prices in London are still set to open higher on Friday, despite October retail sales figures for the UK disappointing shortly before the opening bell.

Read more
17 Nov 2023 07:16

AstraZeneca gets US approval for breast cancer treatment

(Sharecast News) - AstraZeneca's 'Truqap', or capivasertib, in combination with 'Faslodex', or fulvestrant, has secured approval from the US Food and Drug Administration (FDA) for specific breast cancer treatments, the company announced on Friday.

Read more
14 Nov 2023 10:51

TOP NEWS: AstraZeneca Imfinzi fails to meet endpoint in cancer trial

(Alliance News) - AstraZeneca PLC on Tuesday said the Pacific-2 phase III trial for Imfinzi as an early treatment lung cancer immunotherapy treatment administered with chemoradiotherapy, did not meet its primary endpoint.

Read more
14 Nov 2023 09:22

AstraZeneca's latest lung cancer trial fails its primary endpoint

(Sharecast News) - AstraZeneca announced on Tuesday that its 'PACIFIC-2' phase three trial for Imfinzi, or durvalumab, concurrently administered with chemoradiotherapy (CRT), did not achieve its primary endpoint of progression-free survival compared to CRT alone.

Read more
13 Nov 2023 09:45

LONDON BROKER RATINGS: Diageo gets price target cuts; JPMorgan ups M&G

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning:

Read more
9 Nov 2023 15:02

London close: Stocks gain as investors await Powell speech

(Sharecast News) - London's stock markets were buoyant at the close of trading on Thursday, influenced by Chinese inflation data, a substantial influx of corporate news, and a speech from the Fed chair later in the global day.

Read more
9 Nov 2023 12:06

LONDON MARKET MIDDAY: FTSE up despite higher for longer US rates fear

(Alliance News) - European equities were on the up on Thursday, despite lingering US interest rate worries and poor China data.

Read more
9 Nov 2023 11:02

Lancashire Holdings declares special dividend after strong year so far

(Alliance News) - Lancashire Holdings Ltd on Thursday said it approved a capital return of up to USD169 million, and it reported rising gross premiums written for the year-to-date.

Read more
9 Nov 2023 09:23

TOP NEWS: AstraZeneca ups guidance; inks licence deal for obesity drug

(Alliance News) - AstraZeneca PLC on Thursday announced that it signed a contract for an obesity drug as it reported a higher pretax profit in the third quarter of 2023, boosted by cancer drug conjugate Enhertu.

Read more
9 Nov 2023 08:57

LONDON MARKET OPEN: FTSE 100 kicks off day with cautious gain

(Alliance News) - London's FTSE 100 struggled for direction early Thursday, with a mixed slate of corporate updates, US interest rate worries and underwhelming China data preventing it from making more confident progress in early trade.

Read more
9 Nov 2023 07:48

LONDON BRIEFING: AstraZeneca ups outlook but S4 Capital cuts

(Alliance News) - London's FTSE 100 is set for another downbeat start to the day, with more hawkish comments from US central bankers and tepid data out of China doing little to lift the mood.

Read more
9 Nov 2023 07:18

AstraZeneca hikes guidance after strong third quarter

(Sharecast News) - AstraZeneca released its financial results for the third quarter and first nine months of 2023 on Thursday, hiking its full-year guidance on the back of a robust performance and momentum in several segments.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.